Medical School Research Funding Breaks Records in 2020
Feinberg principal investigators secured a record-breaking $643 million in research funding and awards during the 2019-2020 fiscal year.
Browsing: "Medicine"
Northwestern Takes on COVID-19 Antibody Testing
At Northwestern Medicine, various COVID-19 antibody testing efforts have been underway since the beginning of the pandemic.
Sex May Influence Effectiveness of Common Heart Failure Drug
A novel heart failure drug called sacubitril-valsartan reduced the risk of hospitalizations for heart failure and death from cardiovascular causes more in women than in men, according to a study published in Circulation.
Drug Combination May Reduce Risk of Leukemia Relapse
Risk of relapse for chronic myeloid leukemia patients may be reduced through drug combination after discontinuing initial therapy, according to a Northwestern Medicine study published in the journal Leukemia.
Novel Drug Reduces Menstrual Bleeding from Uterine Fibroids
Elagolix, a newly developed orally administered drug, was effective in reducing heavy menstrual bleeding in women with uterine fibroids, according to a recent Northwestern Medicine clinical trial.
2019 in Scientific Images
These images illustrate the physical reality Northwestern scientists work within, striving to uncover the mysteries of biology, chemistry and medicine.
Pediatric Choking Deaths Show Significant 50-Year Decline
Deaths related to choking on objects in children and adolescents — especially among children younger than three years old — have decline steadily for 50 years, according to a study published in JAMA.
Medical Student’s Short Film Raises Awareness About Survivors of Sexual Assault
Mike Boctor, a first-year student, combined his passions for film and medicine by directing an award-winning short film about the healing process for survivors of sexual assault.
Improving the Physician Referral Process with Peer Evaluations
Gregory Brisson, MD, discussed how peer evaluation among physicians could enhance the patient referral process in a recent NEJM editorial.
Overexpression of Enzyme Increases Risk of Treatment Failure in Breast Cancer
The overexpression of mitochondrial superoxide dismutase, commonly found in late-stage tumors, may drive cancer stem cell formation and contribute to the failure of chemotherapy treatment in breast cancer patients.